Cargando…

Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus

The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health. Vaccines are ideal solutions to prevent infection, but treatments are also needed for those who have contracted the virus to limit negative outcomes, when vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitner, Einat B., Achdout, Hagit, Avraham, Roy, Politi, Boaz, Cherry, Lilach, Tamir, Hadas, Yahalom-Ronen, Yfat, Paran, Nir, Melamed, Sharon, Erez, Noam, Israely, Tomer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Accelerated Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904475/ https://www.ncbi.nlm.nih.gov/pubmed/33639165 http://dx.doi.org/10.1016/j.jbc.2021.100470

Ejemplares similares

Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system
por: Avraham, Roy, et al.
Publicado: (2023)

Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2
por: Erez, Noam, et al.
Publicado: (2023)

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
por: Achdout, Hagit, et al.
Publicado: (2021)

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
por: Tamir, Hadas, et al.
Publicado: (2022)

Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains
por: Israely, Tomer, et al.
Publicado: (2019)

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization
por: Noy-Porat, Tal, et al.
Publicado: (2023)

Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities
por: Ben-Shmuel, Amir, et al.
Publicado: (2020)

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2023)

TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines
por: Israely, Tomer, et al.
Publicado: (2014)

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits
por: Rosner, Amir, et al.
Publicado: (2022)

Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination Efficacy
por: Melamed, Sharon, et al.
Publicado: (2021)

Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
por: Vitner, Einat B, et al.
Publicado: (2021)

Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis
por: Melamed, Sharon, et al.
Publicado: (2020)

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2020)

A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease
por: Israely, Tomer, et al.
Publicado: (2012)

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2022)

Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022
por: Paran, Nir, et al.
Publicado: (2022)

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs
por: Madar-Balakirski, Noa, et al.
Publicado: (2022)

Diagnosis of Imported Monkeypox, Israel, 2018
por: Erez, Noam, et al.
Publicado: (2019)

Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
por: Katzman, Chaja, et al.
Publicado: (2021)

Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex
por: Erez, Noam, et al.
Publicado: (2009)

Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism
por: Strobelt, Romano, et al.
Publicado: (2022)

A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
por: Noy-Porat, Tal, et al.
Publicado: (2020)

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
por: Chaouat, Abigael Eva, et al.
Publicado: (2021)

Challenges and Achievements in Prevention and Treatment of Smallpox
por: Melamed, Sharon, et al.
Publicado: (2018)

Parsing the role of NSP1 in SARS-CoV-2 infection
por: Fisher, Tal, et al.
Publicado: (2022)

Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response
por: Paran, Nir, et al.
Publicado: (2013)

HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
por: Domovitz, Tom, et al.
Publicado: (2022)

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments
por: Vagima, Yaron, et al.
Publicado: (2020)

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2022)

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice
por: Gutman, Hila, et al.
Publicado: (2022)

Parsing the role of NSP1 in SARS-CoV-2 infection
por: Fisher, Tal, et al.
Publicado: (2022)

Insights from the Infection Cycle of VSV-ΔG-Spike Virus
por: Milrot, Elad, et al.
Publicado: (2022)

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
por: Israeli, Ma’ayan, et al.
Publicado: (2022)

Glucosylceramide synthase maintains influenza virus entry and infection
por: Drews, Kelly, et al.
Publicado: (2020)

Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens
por: Yefet, Ron, et al.
Publicado: (2023)

ARF6 Regulates Neuron Differentiation through Glucosylceramide Synthase
por: Li, Lu, et al.
Publicado: (2013)

New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression
por: Gupta, Vineet, et al.
Publicado: (2013)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

A Cell-Based Capture Assay for Rapid Virus Detection
por: Milrot, Elad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1bj8kd83vgjo53ouu0es7euma0